AI Bosses: Our Technology Could Make It Easier to Make Bioweapons
AI Bosses: Our Technology Could Make It Easier to Make Bioweapons
https://www.pcmag.com/news/ai-bosses-our-technology-could-make-it-easier-to-make-bioweapons
Publish Date: 2026-06-07 07:07:00
Source Domain: www.pcmag.com
AI may already be designing vaccines that are showing promise in initial human trials, but, if industry leaders are to be believed, applying AI to biochemistry could also have far darker outcomes.
An open letter, signed by many of the biggest names in AI and life sciences, has warned that rapidly advancing AI could erode the “knowledge barriers which have historically prevented bad actors from obtaining biological weapons.”
Signatories included OpenAI CEO Sam Altman, Anthropic CEO Dario Amodei, and Demis Hassabis, CEO of Google DeepMind and a recipient of the 2024 Nobel Prize in Chemistry. Other signees include professors at MIT, Stanford, and the University of California, as well as two former Secretaries of the US Army and Navy.
The signatories are calling on regulators to enforce mandatory screening of all orders for synthetic nucleic acids, which include synthetic DNA and RNA, and the equipment needed to make them. Researchers can order synthetic DNA online to power their research, giving small teams the ability to pursue projects that would otherwise only be available to larger institutions. However, this synthetic DNA could also theoretically be used to make bioweapons, according to peer-reviewed research.
Under the proposals, manufacturers of synthetic DNA and manufacturers of synthesis machines would be forced to check customers’ synthesis requests for “sequences of concern” and to verify “customer legitimacy” before shipping their orders.
Providers would also be forced to record synthesis orders and sequence data to “support biosecurity investigations, tracing any threat back to its source.” The letter highlights research that indicated that AI systems now “outperform PhD-level virologists on questions about highly technical laboratory procedures in their own domains of expertise,” though they acknowledge that evidence on what this means for current biosecurity threats is “genuinely mixed.”
